{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:22:47Z","timestamp":1761060167042,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.rmed.2016.07.004","type":"journal-article","created":{"date-parts":[[2016,7,10]],"date-time":"2016-07-10T00:17:58Z","timestamp":1468109878000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control \u2013 A possible oversight link"],"prefix":"10.1016","volume":"118","author":[{"given":"Jessica Han Ying","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9021-1693","authenticated-orcid":false,"given":"Anne Ann Ling","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2016.07.004_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.iac.2012.11.002","article-title":"Rhinosinusitis and nasal polyps in aspirin exacerbated respiratory disease","volume":"33","author":"Mullol","year":"2013","journal-title":"Immunol. Allergy Clin. N. Am."},{"issue":"3","key":"10.1016\/j.rmed.2016.07.004_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2016.07.004_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1710-1492-4-2-75","article-title":"Aspirin-exacerbated asthma","volume":"4","author":"Varghese","year":"2008","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2016.07.004_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaci.2013.10.057","article-title":"Safety risks for patients with aspirin exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX2 inhibitors: meta-analysis of controlled clinical trials","volume":"134","author":"Morales","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2016.07.004_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/thx.2007.080903","article-title":"Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity","volume":"63","author":"Mastalerz","year":"2008","journal-title":"Thorax"},{"issue":"Suppl.\u00a05","key":"10.1016\/j.rmed.2016.07.004_bib6","first-page":"89","article-title":"Significance of salicylate intolerance in diseases of the lower gastrointestinal tract","volume":"56","author":"Raithel","year":"2005","journal-title":"J.\u00a0Physiol. Pharmacol."},{"issue":"2","key":"10.1016\/j.rmed.2016.07.004_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.survophthal.2009.07.005","article-title":"Nonsteroidal anti-inflammatory drugs in ophthalmology","volume":"55","author":"Kim","year":"2010","journal-title":"Surv. Ophthalmol."},{"issue":"9","key":"10.1016\/j.rmed.2016.07.004_bib8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/096032719601500905","article-title":"Potential dangers from topical preparations containing methyl salicylate","volume":"15","author":"Chan","year":"1996","journal-title":"Hum. Exp. Toxicol."},{"issue":"7","key":"10.1016\/j.rmed.2016.07.004_bib9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1398-9995.2011.02557.x","article-title":"Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) \u2014 classification, diagnosis and management: review of the EAACI\/ENDA and GA2LEN\/HANNA","volume":"66","author":"Kowalski","year":"2011","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.rmed.2016.07.004_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.iac.2012.10.003","article-title":"Genetics of hypersensitivity to aspirin and nonsteroidal anti-inflammatory drugs","volume":"33","author":"Kim","year":"2013","journal-title":"Immunol. Allergy Clin. North Am."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116301512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116301512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:34:07Z","timestamp":1760614447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611116301512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":10,"alternative-id":["S0954611116301512"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2016.07.004","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control \u2013 A possible oversight link","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2016.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}